VitaNova Life Sciences (VNOV) Common Equity (2017 - 2026)
VitaNova Life Sciences (VNOV) posted Common Equity of $1.9 million for Q1 2026, down 2.34% on a QoQ basis from $1.9 million in Q4 2025, and up 67.26% year-over-year from $1.1 million in Q1 2025.
VitaNova Life Sciences (VNOV) Common Equity (2017 - 2026) Analysis & Trends
VitaNova Life Sciences' Common Equity history runs 10 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- Quarterly Common Equity rose 67.26% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $1.9 million (up 67.26% YoY) and the FY2025 annual result came in at $1.9 million, up 80.76% from the prior year.
- Common Equity was $1.9 million for Q1 2026 at VitaNova Life Sciences, down from $1.9 million in the prior quarter.
- Across five years, Common Equity topped out at $1.9 million in Q2 2025 and bottomed at -$92217.0 in Q4 2023.
- A 5-year average of $717559.6 and a median of $870782.0 in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity tumbled 570.21% — and 2024, when it jumped 1883.23%.
- VitaNova Life Sciences' Common Equity stood at -$30253.0 in 2022, then sank by 204.82% to -$92217.0 in 2023, then jumped by 1222.22% to $1.0 million in 2024, then soared by 83.42% to $1.9 million in 2025, then retreated by 2.34% to $1.9 million in 2026.
- Business Quant data shows VNOV's Common Equity at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -2.17 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 3.40 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -2.83 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 1.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 180.93 Mn |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -99.01 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | -464.77 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 10.10 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 1.85 Mn |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 19.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1.85 Mn |
| Oct 31, 2025 | 1.90 Mn |
| Jul 31, 2025 | 1.86 Mn |
| Apr 30, 2025 | 1.91 Mn |
| Jan 31, 2025 | 1.11 Mn |
| Oct 31, 2024 | 1.03 Mn |
| Jul 31, 2024 | 1.00 Mn |
| Apr 30, 2024 | 1.06 Mn |
| Jan 31, 2024 | 870,782.00 |
| Oct 31, 2023 | -92,217.00 |
| Jul 31, 2023 | -83,462.00 |
| Apr 30, 2023 | -59,215.00 |
| Jan 31, 2023 | -54,830.00 |
| Oct 31, 2022 | -30,253.00 |
| Jul 31, 2022 | -32,854.00 |
| Apr 30, 2022 | -34,988.00 |
| Jan 31, 2022 | -8,181.00 |
| Oct 31, 2021 | -17,098.00 |
| Jul 31, 2021 | -32,107.00 |
| Apr 30, 2021 | -174,670.00 |